How to Invest in Nanotechnology?

Global investments in nanotechnology during 2004 were over $8.6 billion worldwide according to Lux Research. The largest sector was still governmental with $4.6 billion, followed by corporate spending of $3.8 billion.

Venture capital investment has already started to nanotechnology-driven companies and more opportunities will arise over the coming years.   There is a lot of interest in the market, and the main question is not "whether" to invest but "when".

A full-day workshop on "How to invest in nanotechnology?" will give comprehensive review on different investor’s views on the market and introduce very interesting companies from different sectors, regions and stages.

Target audience:

•  Venture capitalists
  
•  Strategic investors
  
•  Governmental agencies
  
•  Existing start-ups
  
•  Potential entrepreneurs
  

Agenda 28 April 2005

9:00 Opening
Pekka Koponen, Managing Director, Spinverse Consulting, Finland

09.10 Understanding the whole value chain
Nanotechnology in sporting goods, Case Wilson
Brian Dillman, VP Marketing, Racket Sports, Wilson, USA

09.50 What is nanotechnology?
Nanotechnology 101 for investors.
Matthew Nordan, VP, Research, Lux Research, USA

10.30 Coffee Break

11.00 Governmental Funding
National funding's role in generating new business: Case Finland
Timo Kekkonen, Director General, Technology Department,
Ministry of Trade and Industry, Finland

13.30 EU Funding
European commission nanotechnology funding
Torbjörn Ingemansson, Directorate General for Research - Life Sciences, European Commission

12.00 Lunch

13.30 Corporate Funding
Corporate Venture Capital - leveraging corporate strengths for investment return
Tapio Siik , Nokia Growth Partners

14.00 Venture Capital
What is a VC looking for in a nanotechnology startup?
Stephen Lowery, Senior Associate, 3i plc, UK

14.30 Coffee Break

15.00 Entrepreneurs
Company presentations

Adiabatic Logic, CEO Simon Payne, UK
Frontcoat, CEO Thomas Bill, Denmark
Tech on Tex, CTO Morten Bogedal, Denmark
Beneq, CEO Sampo Ahonen, Finland
Nanolab Systems, CEO Pasi Keinänen, Finland
Nanoway, CEO Juha Kauppinen, Finland

16.30 - 17.30 Cocktails & Networking


Congress Program 28 April 2005 >>

Admission

Admission to the Investor Workshop is included in the NTNE congress registration fee. Alternatively, admission fee to the investor workshop only is 250 eur.

ONLINE REGISTRATION IS CLOSED!

You can register at the Helsinki Fair Centre, congress registration desk (by the main entrance), starting Tuesday 26 April 2005, at 8:00.




See also :

Investments in Biotechnology

BioFinland 05 Investor Forum is a unique two-day conference (26- 27 April 2005 Helsinki , Finland)) offering the opportunity to listen to 16 business presentations of promising biotech firms in Finland and ScanBalt Area and to meet investors as well as executives from some of the global top life science companies.

Top speakers from the global biotech financing and scientific circles give you an up to the minute insight into the sector, including G. Steven Burrill, CEO of Burrill & Company, Nigel Parker, CEO of Ark Therapeutics Group plc, Yann Bonduelle, Head of UK Valuation and strategy, PWC Corporate Financing and Neil D. Cook, Vice President, R&D and CSO of PerkinElmer Corporation.

More information: www.biofinland.fi/investorforum >>